Conviction
$ Value
$12K
Shares
4,392
Price
$3
Filed
Aug 18
▶ Why this score? (4/10)
- ✓ Open market buy (+3)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Hebbar Sudarshan
Title
Chief Medical Officer
CIK
0001968793
Roles
Transaction Details
Transaction Date
2025-08-15
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
51,976
Footnotes
The weighted average purchase price for the transaction reported was $2.585, and the range of prices were between $2.57 and $2.61. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided. | The weighted average purchase price for the transaction reported was $2.7930, and the range of prices were between $2.70 and $2.85. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
Filing Info
Hebbar Sudarshan's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-08-19 | CALC | ▲ | $27K ★ |
| 2025-08-15 | CALC | ▲ | $12K |
| 2025-08-14 | CALC | ▲ | $4K |
| 2025-06-24 | CALC | A | $0 |
| 2025-04-23 | CALC | A | $0 |
| 2025-04-05 | CALC | A | $0 |
Other Insiders at CALC (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Leheny A. Rachel
CHIEF EXECUTIVE OFFICER
|
— | — | 2025-04-05 |
|
Roberts Eric W
CHIEF BUSINESS OFFICER
|
— | — | 2025-04-05 |
|
Bardin Stephen
Chief Financial Officer
|
— | — | 2025-04-05 |
|
Dunn Michael J.
President and COO
|
— | — | 2025-04-05 |
|
Hebbar Sudarshan
Chief Medical Officer
|
— | — | 2025-04-05 |
|
Stauderman Kenneth A.
Chief Scientific Officer
|
— | — | 2025-04-05 |